New Insights into Gastric Cancer Treatment: Uncovering Novel Therapeutic Targets

Strategic Insights -

Research from Hangzhou Normal University, in collaboration with various institutions, has shed light on potential therapeutic targets for gastric cancer, a disease with poor prognosis and limited treatment options. The study focused on understanding the inflammatory and protein-protein interaction hub networks that drive tumor progression. By analyzing gene expression and protein-protein interactions, the researchers identified 18 genes that could serve as biomarkers for gastric cancer and may guide the development of precision immunotherapies.

Key Takeaways:

  • Gastric cancer ranks second in incidence and mortality among digestive system cancers, highlighting the need for effective treatment options.
  • The study identified 69 differentially expressed genes (DEGs) in gastric cancer, with 8 inflammatory response-related DEGs (IRR-DEGs) closely associated with 19 types of immune cells and various lymphocytes.
  • The researchers discovered 12 hub genes that are significantly enhanced in stem cells, primarily involving communication with monocytes, and four prognostic-related genes were identified.
  • The SPP1 signaling pathway, specifically the SPP1-CD44 ligand-receptor pairs, was found to play a critical role in driving tumor progression.
  • The study laid the foundation for developing precision immunotherapies that target the inflammatory-immune axis in GC management.

Statistics:

  • 69 DEGs were identified in gastric cancer.
  • 8 IRR-DEGs (SPP1, TIMP1, SERPINF1, TNFAIP6, LGALS1, LY6E, MSR1, and SELE) were closely associated with 19 types of immune cells and various lymphocytes.
  • 12 hub genes were identified, with their expression significantly enhanced in stem cells.
  • 4 prognostic-related genes were discovered.
  • 18 genes were identified as potential biomarkers for gastric cancer.

Sources:

  • Revealing Potential Therapeutic Targets In Gastric Cancer Through Inflammation and Protein-protein Interaction Hub Networks. Journal of Cancer, 2025;16(8):2720-2736.
  • NewsRx. New Findings from Hangzhou Normal University Update Understanding of Gastric Cancer (Revealing Potential Therapeutic Targets In Gastric Cancer Through Inflammation and Protein-protein Interaction Hub Networks). Immunotherapy Weekly. July 23, 2025; p 2520.